SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MultiCell Technologies, Inc.
MCET 0.000001000-90.0%Jun 6 1:41 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jimpit who wrote (175)10/7/2006 2:41:28 PM
From: jimpit  Read Replies (1) of 237
 
And another copied from the RB site.

d. for j.
_____________________________________________________________
EQUITIES MAGAZINE
Summer 2006

MultiCell Technologies in Transition

"MultiCell brought in twice-retired drug hunter CEO Stephen Chang, Ph.D, as its turnaround president in 2005. Since then, the stem cell technology company has developed an exciting drug development pipeline, targeting Multiple Sclerosis, Type-1 diabetes, flu and macular degeneration."

equitiesmagazine.com

(Pages 76 and 77)
_____________________________________________________________
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext